Monoclonal Antibodies for MS Treatments MStranslate October 20, 2016 Research, Understanding Science By Brett Drummond What’s in a name? I was recently asked a question: “Why do all of the new MS drugs end in mab? Does that mean...
Rates of MS Progression: Dr Tomas Kalincik (MSBase) MStranslate October 11, 2016 Q&A, Research Upon his return from ECTRIMS 2016, Dr Tomas Kalincik from the Melbourne Brain Centre at Royal Melbourne Hospital spoke to MStranslate about...
Clinically Stable MS & Magnetic Resonance Imaging MStranslate October 3, 2016 Neuroimaging, Research What is clinically stable multiple sclerosis? As most of you might be aware, the most common form of multiple sclerosis is relapsing-remitting MS...
ECTRIMS 2016: An Overview of Key Outcomes MStranslate September 22, 2016 Conferences, ECTRIMS, Research, Social Media Each year, the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) holds the largest MS research meeting in the world. ...
The ‘Publish’ or ‘Perish’ Pressure of Research MStranslate September 15, 2016 Opinion 1 Comment The Funding Flaws of Research By Tahlia, B Sci (Hons), University of Melbourne The pressure that so many researchers feel to secure competitive...
High-dose Biotin Clinical Trial Results MStranslate September 13, 2016 Biotin, Clinical Trials, Research, Treatments 1 Comment Research Summary: MD1003 (high-dose biotin) for the treatment of multiple sclerosis: A randomised, double-blind, placebo-controlled study The...
New Studies Question Gene Mutation Link to MS MStranslate September 12, 2016 Genetics, Research The results of an MS genetic study published in Neuron earlier this year are now being called into question. You may remember that MStranslate did a...
The Misdiagnosis of Multiple Sclerosis: A Study MStranslate September 1, 2016 Research A study has provided evidence to something that has been discussed anecdotally for quite some time - a diagnosis of multiple sclerosis (MS) is...
MOMENTUM Phase II Trial Results MStranslate August 22, 2016 Clinical Trials, Fingolimod, Research The background Fingolimod was approved in 2010 and became the first oral drug for the treatment of relapsing-remitting MS (RRMS). It has proven to...
EAE Study Shows Multiple Benefits of Exercise MStranslate August 1, 2016 Exercise, Lifestyle, Research The background It is known that problems with the blood-brain barrier (BBB) and the immune system contribute to the damage seen in multiple...
